BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 18258853)

  • 1. Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation.
    Feng Y; Yue X; Xia H; Bindom SM; Hickman PJ; Filipeanu CM; Wu G; Lazartigues E
    Circ Res; 2008 Mar; 102(6):729-36. PubMed ID: 18258853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme 2: a new player in central sympathetic regulation?
    Zucker IH
    Circ Res; 2008 Mar; 102(6):628-9. PubMed ID: 18369160
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice.
    Bindom SM; Hans CP; Xia H; Boulares AH; Lazartigues E
    Diabetes; 2010 Oct; 59(10):2540-8. PubMed ID: 20660625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension.
    Feng Y; Xia H; Cai Y; Halabi CM; Becker LK; Santos RA; Speth RC; Sigmund CD; Lazartigues E
    Circ Res; 2010 Feb; 106(2):373-82. PubMed ID: 19926873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice.
    Chhabra KH; Xia H; Pedersen KB; Speth RC; Lazartigues E
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E874-84. PubMed ID: 23462816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension.
    Sriramula S; Cardinale JP; Lazartigues E; Francis J
    Cardiovasc Res; 2011 Dec; 92(3):401-8. PubMed ID: 21952934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice.
    Xia H; Feng Y; Obr TD; Hickman PJ; Lazartigues E
    Hypertension; 2009 Feb; 53(2):210-6. PubMed ID: 19124678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.
    Xia H; Sriramula S; Chhabra KH; Lazartigues E
    Circ Res; 2013 Oct; 113(9):1087-1096. PubMed ID: 24014829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain ACE2 overexpression reduces DOCA-salt hypertension independently of endoplasmic reticulum stress.
    Xia H; de Queiroz TM; Sriramula S; Feng Y; Johnson T; Mungrue IN; Lazartigues E
    Am J Physiol Regul Integr Comp Physiol; 2015 Mar; 308(5):R370-8. PubMed ID: 25519733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe food restriction activates the central renin angiotensin system.
    De Souza AMA; Linares A; Speth RC; Campos GV; Ji H; Chianca D; Sandberg K; De Menezes RCA
    Physiol Rep; 2020 Jan; 8(1):e14338. PubMed ID: 31925945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism.
    Deshotels MR; Xia H; Sriramula S; Lazartigues E; Filipeanu CM
    Hypertension; 2014 Dec; 64(6):1368-1375. PubMed ID: 25225202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-1-derived PGE2 and PGE2 type 1 receptors are vital for angiotensin II-induced formation of reactive oxygen species and Ca(2+) influx in the subfornical organ.
    Wang G; Sarkar P; Peterson JR; Anrather J; Pierce JP; Moore JM; Feng J; Zhou P; Milner TA; Pickel VM; Iadecola C; Davisson RL
    Am J Physiol Heart Circ Physiol; 2013 Nov; 305(10):H1451-61. PubMed ID: 24014678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
    Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
    J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.
    Wysocki J; Ye M; Rodriguez E; González-Pacheco FR; Barrios C; Evora K; Schuster M; Loibner H; Brosnihan KB; Ferrario CM; Penninger JM; Batlle D
    Hypertension; 2010 Jan; 55(1):90-8. PubMed ID: 19948988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the renin-angiotensin system, specifically in the subfornical organ is sufficient to induce fluid intake.
    Coble JP; Cassell MD; Davis DR; Grobe JL; Sigmund CD
    Am J Physiol Regul Integr Comp Physiol; 2014 Aug; 307(4):R376-86. PubMed ID: 24965793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway.
    Koka V; Huang XR; Chung AC; Wang W; Truong LD; Lan HY
    Am J Pathol; 2008 May; 172(5):1174-83. PubMed ID: 18403595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.
    Ye M; Wysocki J; Gonzalez-Pacheco FR; Salem M; Evora K; Garcia-Halpin L; Poglitsch M; Schuster M; Batlle D
    Hypertension; 2012 Sep; 60(3):730-40. PubMed ID: 22777933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy.
    Feng Y; Hans C; McIlwain E; Varner KJ; Lazartigues E
    PLoS One; 2012; 7(11):e48910. PubMed ID: 23155428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-Converting Enzyme 2 Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysms in Mice.
    Hao Q; Dong X; Chen X; Yan F; Wang X; Shi H; Dong B
    Hum Gene Ther; 2018 Dec; 29(12):1387-1395. PubMed ID: 28142259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro.
    Haber PK; Ye M; Wysocki J; Maier C; Haque SK; Batlle D
    Hypertension; 2014 Apr; 63(4):774-82. PubMed ID: 24446061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.